Duk da haka ba a amince da FDA ba
Ampligen (rintatolimod) a cikin maganin maganin rigakafin gwaji, tsarin maganin rigakafi wanda ke aiki a cikin shekaru 30. Ana binciken shi a matsayin yiwuwar magani ga yanayin da yawa, ciki har da ciwo mai tsanani (CFS ko ME / CFS ), HIV / AIDs , wasu cututtukan da ke fama da ciwon daji , da ciwon gyada da furotin (H1N1) , da cutar Ebola.
A shekara ta 2009 kuma a shekarar 2013, FDA ta ƙi Ampligen a matsayin magani na ME / CFS.
Zai kasance farkon hanyar da aka amince da ita don wannan yanayin da kuma samar da ƙofar Ampligen a kasuwa. Duk da irin wadannan lalacewar, mai sana'a na ci gaba da tafiya gaba don samun wannan magani.
Ta Yaya Ayyukan Tsarin Halitta?
An yi amfani da Ampligen don yin aiki ta hanyar tsalle-tsire-tsire ta hanyar hanyar maganin rigakafi na jikinka da kuma matakan daidaitawa na RNase L (wani abu a jikinka wanda ke kaiwa ƙwayoyin cuta), wanda zai iya kasancewa a cikin mutane tare da ME / CFS. Haka kuma an nuna shi ya hana ci gaban kwayar ƙwayar ƙwayar cuta.
Ampligen ba ya bayyana don kawar da tsarin rigakafi ba. Maimakon haka, an yi imani da canza canjin da tsarinka yana aiki.
Aminiya don Ciwo na Yara da Bala'i
A gwaje-gwaje na asibiti, an nuna Ampligen don inganta cognition, motsa jiki haƙuri, lafiyar neuropsychology da kuma cikakken aiki a cikin mutane tare da ME / CFS; rage aikin HHV-6 (wata ƙwayar cutar ta amince cewa an haɗa shi da ME / CFS), kuma rage aikin RNase L.
Bisa ga masana'antar Ampligen, Hemispherx Biopharma Inc., an bayar da kimanin fiye da 40,000 na Ampligen game da marasa lafiya 500 a gwaje-gwaje na asibiti a fiye da 20 asibitin Amurka. Ɗaya daga cikin wadannan asibitoci, Cibiyar Hunter-Hopkins, ta ce kashi 80 cikin 100 na marasa lafiya sun inganta a kan Ampligen, kuma 50% na inganta sosai.
Saboda Ampligen ba'a amince da shi ba don kowane amfani a Amurka, ƙananan kamfanoni da izini na musamman zasu iya rubuta Ampligen. Har ila yau, yana da tsada sosai - kamar yadda a cikin fiye da $ 40,000 a shekara! Kuma ba, inshora ba zai rufe shi, saboda yana gwaji.
Har ila yau, Ampligen ya kasance marar amincewa a Ƙungiyar Tarayyar Turai, amma wasu marasa lafiya a can za su iya samun ta ta hanyar abin da ake kira "shirin gaggawa."
Magungunan Ampligen
Ana amfani da Ampligen a cikin intravenously (IV). A gwaje-gwaje da kuma takardar izini ta FDA, marasa lafiya sun karbi kimanin mita 400 na miyagun ƙwayoyi sau biyu a mako. Hunter-Hopkins na bada shawarar a kwalla tsawon watanni 12 da kuma watanni 18 don rashin lafiya.
Hanyoyin Harshen Ampligen
Kamar kowane miyagun ƙwayoyi, Ampligen na iya haifar da sakamako mai lalacewa maras so. Abubuwan da zasu iya yiwuwa sun haɗu da:
- M flushing,
- Tightness na kirji,
- Rapid heartbeat,
- Raguwa,
- Rawancin numfashi,
- Jin zafi,
- Sweating,
- Nausea,
- Harshen enzyme na haɓaka ya canza,
- Diarrhea,
- Itching,
- Low saukar karfin jini,
- Rash,
- Arrhythmias,
- Rawan jini mai ƙananan jini,
- Dizziness,
- Rikici.
Wasu marasa lafiya suna da alamun bayyanar cututtuka na 'yan sa'o'i kadan bayan sun karbi maganin miyagun ƙwayoyi. Mai sana'a ya ce wadannan abubuwa sun wuce bayan wasu watanni na jiyya.
Sources:
Smith ME, et al. Annals na magani na gida. 2015 Yuni 16; 162 (12): 841-50. Jiyya na maganin ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar cuta / ciwo mai wuya: nazari na yau da kullum ga Cibiyar Nazarin Harkokin Kiwon Lafiyar Jama'a na Ƙungiyar Harkokin Kiwon Lafiyar.
Strayer DR, et al. PLoS Daya. 2012; 7 (3): e31334. Ƙaramar makafi guda biyu, matsin lamba, bazuwa, gwaji na gwaji na Tintr-3 dan rintatolimod a cikin lokuta masu tsanani na ciwo na gajiya.
Strayer DR, et al. Clinical cututtuka. 1994 Janairu 18 Tsara 1: S88-95. Gwajin gwaji mai sarrafawa tare da magungunan RNA da aka ƙayyade musamman, poly (I) .poly (C12U), a cikin ciwo mai wuya.
Suhadolnik RJ, et al. A cikin vivo. 1994 Jul-Aug 8 (4): 599-604. Canje-canje a cikin tsarin tsarin antiviral 2ESA na 2-5A a cikin gwajin gwagwarmaya ta gwaji tare da poly (I) -poly (C12U) a cikin ciwo mai wuya.